Key result
Medical treatment adjustment in a 44-year-old male with Covid-19 associated myocarditis, CAD, and ESRD resulted in markedly improved LVEF and left ventricular GLS at 3 months.
Why the study?
Little is known about the true nature and exact pathogenesis of myocardial involvement in patients with Covid-19 infection.
Case Report (n=1)
Medical treatment adjustment can lead to marked improvement in LVEF and GLS in patients with Covid-19 associated myocarditis and complex comorbidities.
Answers are grounded in this paper and cite their sources.
May support LV recovery with therapy adjustment in COVID-19 myocarditis; hypothesis-generating and requires prospective validation before practice change.
Myocarditis is associated with increased morbidity and mortaity in patients with Covid-19 infection. Little is known about the true nature and exact pathogenesis of myocardial involvement in these patients. 44 year old patient admitted with exertional dyspnea. He had previous coronary artery bypass surgey and received hemodialysis for lupus nephritis. He was diagnosed with Covid-19 infection 1 month ago. Echocardiography revealed decreased left ventricular ejection fraction and left ventricular global longitudinal strain (GLS). Coronary computerized tomographic angiography revealed patent bypass grafts. His medical treatment was adjusted. Follow up echocardiography after 3 months showed markedly improved LVEF and left ventricular GLS.
No takes yet. Share an insight, caveat, or question.
Şimşek et al. (2024) conducted a case report in Covid-19 associated myocarditis (n=1). Medical treatment adjustment was evaluated on Left ventricular ejection fraction (LVEF) and left ventricular global longitudinal strain (GLS). Medical treatment adjustment in a 44-year-old male with Covid-19 associated myocarditis, CAD, and ESRD resulted in markedly improved LVEF and left ventricular GLS at 3 months.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: